Knight Therapeutics Inc.

C$11.42As of Sun 8 Nov 2026, 12:00 UTC
TSX:GUDHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR 2.50%
Div yield —
ROE 2.05%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.02
PE TTM 71.29
TSR TTM 95.55%
Mkt cap C$1.122B
ROIC 3.90%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$15
29.03%
(80.01%)
Hold 7|4|9|12|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.20
0.22
0.22
0.24
(3.25%)
13.64%
4.46%
19.84%
Revenue$M
62.83
63.99
64.20
66.91
8.54%
6.70%
9.69%
10.14%
Peers (US$794.0M)
Cap (US$)
PE
1.330B
23.31x
746.9M
12.54x
Capital
TTM
5Y
10Y
Leveragex
0.440
0.138
0.088
EBIT/Intx
0.835
0.525
0.429
Own earn%
(844.76)
(57.58)
(60.97)
Sh yield%
18.90
38.87
30.94
Owners
Insiders/Inst%
14.24
72.48
Short interest%
1.24
SBC / revenue%
0.49
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
11–17
$1 testx
—
Incr. ROIC%
13